STOCK TITAN

Humana and Interwell Health Announce Addition of State of Florida to Value-based Kidney Care Program

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

Humana Inc. (NYSE: HUM) and Interwell Health have expanded their value-based care agreement to include Florida for eligible Humana Medicare Advantage members with chronic kidney disease (CKD) and end-stage kidney disease (ESKD). This expansion brings Interwell's support services to 14 states for CKD members and 39 states for ESKD members.

The program offers comprehensive care and specialized resources, including access to 2,000 network nephrologists and various healthcare professionals. Humana reported a 5% reduction in unnecessary hospital admissions in 2023 through its value-based kidney care partnerships. The expansion aims to improve patient outcomes and quality of life for the growing number of adults living with kidney disease.

Humana Inc. (NYSE: HUM) e Interwell Health hanno ampliato il loro accordo di assistenza basata sul valore per includere la Florida per i membri idonei di Humana Medicare Advantage affetti da malattie renali croniche (CKD) e malattie renali allo stadio terminale (ESKD). Questa espansione porta i servizi di supporto di Interwell a 14 stati per i membri con CKD e 39 stati per i membri con ESKD.

Il programma offre assistenza completa e risorse specializzate, inclusi l'accesso a 2.000 nefrologi della rete e vari professionisti sanitari. Humana ha riportato una riduzione del 5% delle ammissioni ospedaliere non necessarie nel 2023 attraverso le sue partnership per l'assistenza renale basata sul valore. L'espansione mira a migliorare i risultati per i pazienti e la qualità della vita per il numero crescente di adulti che vivono con malattie renali.

Humana Inc. (NYSE: HUM) e Interwell Health han ampliado su acuerdo de atención basada en el valor para incluir Florida para los miembros elegibles de Humana Medicare Advantage con enfermedad renal crónica (CKD) y enfermedad renal en etapa terminal (ESKD). Esta expansión lleva los servicios de apoyo de Interwell a 14 estados para miembros con CKD y 39 estados para miembros con ESKD.

El programa ofrece atención integral y recursos especializados, incluyendo acceso a 2,000 nefrólogos de la red y varios profesionales de la salud. Humana reportó una reducción del 5% en las admisiones hospitalarias innecesarias en 2023 a través de sus asociaciones de atención renal basada en el valor. La expansión tiene como objetivo mejorar los resultados para los pacientes y la calidad de vida de un número creciente de adultos que viven con enfermedades renales.

휴마나 주식회사 (NYSE: HUM)와 인터웰 헬스는 가치 기반 의료 계약을 플로리다로 확장했습니다, 만성 신장 질환(CKD) 및 말기 신장 질환(ESKD) 환자인 휴마나 메디케어 어드밴티지 회원을 위해. 이 확장은 인터웰의 지원 서비스를 CKD 회원을 위한 14개 주와 ESKD 회원을 위한 39개 주로 확대합니다.

이 프로그램은 2,000명의 네트워크 신장 전문의와 다양한 의료 전문직에 대한 접근을 포함하여 포괄적인 치료 및 전문 자원을 제공합니다. 휴마나는 가치 기반 신장 치료 파트너십을 통해 2023년에 불필요한 입원율을 5% 감소시켰습니다. 이 확장의 목표는 신장 질환을 앓고 있는 성인들의 수가 증가함에 따라 환자 결과와 삶의 질을 개선하는 것입니다.

Humana Inc. (NYSE: HUM) et Interwell Health ont étendu leur accord de soins basés sur la valeur pour inclure la Floride pour les membres éligibles de Humana Medicare Advantage souffrant de maladies rénales chroniques (CKD) et de maladies rénales en phase terminale (ESKD). Cette expansion porte les services de soutien d'Interwell à 14 États pour les membres CKD et 39 États pour les membres ESKD.

Le programme propose des soins complets et des ressources spécialisées, y compris un accès à 2 000 néphrologues du réseau et divers professionnels de santé. Humana a signalé une réduction de 5 % des admissions hospitalières non nécessaires en 2023 grâce à ses partenariats de soins rénaux basés sur la valeur. L'expansion vise à améliorer les résultats pour les patients et la qualité de vie d'un nombre croissant d'adultes souffrant de maladies rénales.

Humana Inc. (NYSE: HUM) und Interwell Health haben ihren wertbasierten Versorgungsvertrag auf Florida ausgeweitet, um berechtigte Humana Medicare Advantage-Mitglieder mit chronischer Nierenerkrankung (CKD) und terminaler Nierenerkrankung (ESKD) einzubeziehen. Diese Erweiterung bringt die Unterstützungsdienste von Interwell auf 14 Bundesstaaten für CKD-Mitglieder und 39 Bundesstaaten für ESKD-Mitglieder.

Das Programm bietet umfassende Versorgung und spezialisierte Ressourcen, einschließlich Zugang zu 2.000 Netzwerk-Nephrologen und verschiedenen Gesundheitsfachkräften. Humana berichtete von einer 5%igen Reduzierung der unnötigen Krankenhausaufenthalte im Jahr 2023 durch seine wertbasierten Nierenpflegepartnerschaften. Ziel der Erweiterung ist es, die Patientenergebnisse und die Lebensqualität der wachsenden Zahl von Erwachsenen mit Nierenerkrankungen zu verbessern.

Positive
  • Expansion of value-based kidney care program to Florida, potentially increasing Humana's market reach
  • 5% reduction in unnecessary hospital admissions in 2023 for kidney care partnerships
  • Access to 2,000 network nephrologists and specialized healthcare professionals for members
  • Comprehensive care model potentially improving patient outcomes and quality of life
Negative
  • None.

Insights

The expansion of Humana and Interwell Health's value-based kidney care program to Florida is a significant development in the healthcare sector. This move potentially impacts millions of Medicare Advantage members living with chronic kidney disease (CKD) and end-stage kidney disease (ESKD).

The program's expansion demonstrates a growing trend towards value-based care models in managing chronic conditions. By focusing on patient-centered, coordinated care, this approach aims to improve health outcomes while potentially reducing healthcare costs. The reported 5% reduction in unnecessary hospital admissions in 2023 is a promising indicator of the program's effectiveness.

For investors, this expansion signals Humana's commitment to innovation in healthcare delivery and cost management. It could lead to improved member retention and attraction of new enrollees, potentially boosting Humana's market share in the competitive Medicare Advantage space. However, the long-term financial impact will depend on the program's ability to consistently deliver cost savings and improved health outcomes at scale.

The collaboration between Humana and Interwell Health represents a significant advancement in kidney care management. By integrating 2,000 network nephrologists with a multidisciplinary team of renal care coordinators, dietitians, nurses, social workers and pharmacists, this program offers a comprehensive approach to kidney disease management.

This model addresses a critical need, as CKD affects a large and growing population. The focus on early intervention and coordinated care could potentially slow disease progression and improve quality of life for patients. The pre-emptive kidney transplant case mentioned is particularly noteworthy, as it demonstrates the program's potential to achieve optimal outcomes through proactive management.

From a medical perspective, this approach aligns with best practices in kidney care. The challenge will be in scaling this model effectively across diverse patient populations and healthcare systems. Success will depend on consistent execution and the ability to adapt to individual patient needs while maintaining cost-effectiveness.

LOUISVILLE, Ky.--(BUSINESS WIRE)-- Leading health and well-being company Humana Inc. (NYSE: HUM), and kidney care management company Interwell Health, have expanded their value-based care agreement to include Florida for eligible Humana Medicare Advantage members living with chronic kidney disease (CKD) and end-stage kidney disease (ESKD). Interwell’s value-based support services are now available in 14 states for eligible members with CKD, and in 39 states for eligible members living with ESKD.

Value-based care is a holistic, patient-centered healthcare model that focuses on a coordinated effort to help improve patient health outcomes and quality of life, and members in this program now have access throughout their healthcare journey to Interwell’s comprehensive care and specialized resources, including 2,000 network nephrologists, renal care coordinators, and in-home virtual support from dietitians, nurses, social workers, pharmacists, and care coordinators.

“Tens of millions of American adults currently live with chronic kidney disease,” said Caraline Coats, Florida Medicare President at Humana. “As the numbers continue to grow, so is the need to provide our members living with chronic and end-stage kidney disease with access to value-based, coordinated care. We are grateful to be able to bring this program to Florida.”

Humana recently released an issue brief documenting its success in value-based partnerships for kidney care, including a 5% reduction in unnecessary hospital admissions in 2023. That issue brief highlighted the story of Mary Johnson who received a successful pre-emptive kidney transplant off the waiting list after receiving support from the Interwell care team.

"We are proud of this opportunity to serve even more Humana members with kidney disease and help them to live their best lives,” said Dr. George Hart, Chief Medical Officer of Interwell Health. “We know we can make a difference when patients receive support from a dedicated care team built to support their unique needs, while also benefiting from a highly engaged provider network committed to value-based care. Together we are improving patient outcomes.”

You can find out more information about Humana’s Kidney Care programs here.

About Humana

Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

About Interwell Health

As a leading provider of value-based kidney care, Interwell Health is on a mission to reimagine healthcare to help patients live their best lives. Interwell is setting the standard for the industry by producing sustainable savings and driving exceptional quality results at unmatched scale. The company leverages a two-pronged approach that includes total patient care and provider enablement to serve patients with chronic kidney disease (CKD) from stage 3 to kidney failure. In partnership with more than 2,000 nephrologists, the Interwell interdisciplinary care team leverages advanced machine learning algorithms to personalize care for patients in all 50 states and Puerto Rico. To learn more, visit interwellhealth.com.

Other providers are available in the Humana network. Provider may also contract with other plan sponsors.

Y0040_GCHMG89EN_C

Lisa Dimond

Humana Corporate Communications

832-330-4702

ldimond@humana.com



Brad Puffer

Interwell Health Corporate Communications

781-460-4820

bpuffer@interwellhealth.com

Source: Humana Inc.

FAQ

What states are now covered by Humana and Interwell Health's kidney care program?

Interwell's value-based support services are now available in 14 states for eligible members with chronic kidney disease (CKD), and in 39 states for eligible members living with end-stage kidney disease (ESKD).

How has Humana's kidney care program impacted hospital admissions?

Humana reported a 5% reduction in unnecessary hospital admissions in 2023 through its value-based partnerships for kidney care.

What resources are available to Humana members in the expanded kidney care program?

Members have access to 2,000 network nephrologists, renal care coordinators, and in-home virtual support from dietitians, nurses, social workers, pharmacists, and care coordinators.

How many adults in America are affected by chronic kidney disease, according to Humana (HUM)?

According to Caraline Coats, Florida Medicare President at Humana, tens of millions of American adults currently live with chronic kidney disease.

Humana Inc.

NYSE:HUM

HUM Rankings

HUM Latest News

HUM Stock Data

33.36B
120.41M
0.22%
97.79%
3.14%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States of America
LOUISVILLE